Sicor, in Northern Italy, is part of the Teva API business, and provides a global platform for the manufacture and marketing of APIs for injectable, inhalation, topical and nasal products. These specialized plants possess a high level of expertise, producing about 60 active pharmaceutical ingredients.
| Website | http://www.tapi.com/ |
| Revenue | $5.8 million |
| Employees | 191 (64 on RocketReach) |
| Phone | +351 256 759 200 |
| Fax | +351 256 759 299 |
| Industry | Pharmaceutical Manufacturing, Textiles & Apparel, Consumer Goods, Manufacturing |
| Web Rank | 6 Million |
| Keywords | Api Manufacturing, Pharmaceutical Manufacturing, Active Pharmaceutical Ingredients, Pharmaceutical Api, Pharmaceutical Ingredients, Drug Development, Drug Production, Injectable Drugs, Specialty Pharmaceuticals, Drug Formulation, Medicinal Manufacturing, Sterile Manufacturing, Medicine Production, Pharmaceutical Supplies, Healthcare Manufacturing, Contract Manufacturing |
| Competitors | Roche, Amgen, Boehringer Ingelheim, Baxter International Inc., Teva Pharmaceuticals, Sandoz, Fresenius Kabi, Cipla, Aurobindo Pharma LTD, Mylan Belgium +43 more (view full list) |
| SIC | SIC Code 22 Companies, SIC Code 229 Companies |
| NAICS | NAICS Code 3149 Companies, NAICS Code 31 Companies, NAICS Code 31499 Companies, NAICS Code 314 Companies |
Looking for a particular Sicor employee's phone or email?
The Sicor annual revenue was $5.8 million in 2026.
Fabrizio Bertini is the CEO of Sicor.
64 people are employed at Sicor.
The NAICS codes for Sicor are [3149, 31, 31499, 314].
The SIC codes for Sicor are [22, 229].